Login Register Cart 0
Generic placeholder image

Current HIV Research

Editor-in-Chief

ISSN (Print): 1570-162X
ISSN (Online): 1873-4251

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

An HIV-Positive Patient Presenting with Malignant Bone Tumor in Left Tibia Treated with Microwave Ablation for Limb Salvage

Author(s): Tongshuan Gao, Chuan Dong, Minghua Zhang, Rui Ding, Yindi Yang and Zhe Yu*

Volume 19, Issue 1, 2021

Published on: 19 August, 2020

Page: [90 - 95] Pages: 6

DOI: 10.2174/1570162X18999200819145844

Price: $65

Abstract

Background: We report on a patient with human immunodeficiency virus (HIV)-positive disease with a malignant bone tumor in the left proximal tibia treated with surgery using microwave ablation (MWA).

Case Presentation: A 50-year-old Chinese male presented with sudden pain in the left knee and weight loss that had begun 2 months prior to his visit. The preoperative X-ray and MRI scan both demonstrated significant osteolytic destruction in the left proximal tibia surrounded with soft tissue mass. The patient underwent limb salvage surgery for his left leg with the technique of microwave ablation in situ. The pathology revealed myofibroblastic sarcoma with no positive margins, stage T2N0M0. The patient has a satisfactory functional and cosmetic limb with no evidence of disease at a follow-up time of 2 years.

Conclusion: MWA is a feasible and effective surgical method for the limb salvage operation, especially for the patient with poor immunological function, e.g., HIV infection. It might offer an innovative and distinctive therapeutic alternative for malignant bone tumors, while avoiding prosthesis replacement.

Keywords: HIV, AIDS, malignant bone tumor, limb salvage surgery, microwave ablation, hyperthermia.

« Previous Next »
Graphical Abstract

[1]
Cornelis FH, Marcelin C, Bernhard JC. Microwave ablation of renal tumors: A narrative review of technical considerations and clinical results. Diagn Interv Imaging 2017; 98(4): 287-97.
[http://dx.doi.org/10.1016/j.diii.2016.12.002] [PMID: 28011104]
[2]
Dou JP, Liang P, Yu J. Microwave ablation for liver tumors. Abdom Radiol (NY) 2016; 41(4): 650-8.
[http://dx.doi.org/10.1007/s00261-016-0662-6] [PMID: 26880177]
[3]
Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology 2007; 72(Suppl. 1): 124-31.
[http://dx.doi.org/10.1159/000111718] [PMID: 18087193]
[4]
Lucchina N, Tsetis D, Ierardi AM, et al. Current role of microwave ablation in the treatment of small hepatocellular carcinomas. Ann Gastroenterol 2016; 29(4): 460-5.
[http://dx.doi.org/10.20524/aog.2016.0066] [PMID: 27708511]
[5]
Meloni MF, Chiang J, Laeseke PF, et al. Microwave ablation in primary and secondary liver tumours: technical and clinical approaches. Int J Hyperthermia 2017; 33(1): 15-24.
[http://dx.doi.org/10.1080/02656736.2016.1209694] [PMID: 27416729]
[6]
Moussa AM, Ziv E, Solomon SB, Camacho JC. Microwave ablation in primary lung malignancies. Semin Intervent Radiol 2019; 36(4): 326-33.
[http://dx.doi.org/10.1055/s-0039-1700567] [PMID: 31680724]
[7]
Sidoff L, Dupuy DE. Clinical experiences with microwave thermal ablation of lung malignancies. Int J Hyperthermia 2017; 33(1): 25-33.
[http://dx.doi.org/10.1080/02656736.2016.1204630] [PMID: 27411731]
[8]
Vogl TJ, Naguib NN, Lehnert T, Nour-Eldin NE. Radiofrequency, microwave and laser ablation of pulmonary neoplasms: clinical studies and technical considerations--review article. Eur J Radiol 2011; 77(2): 346-57.
[http://dx.doi.org/10.1016/j.ejrad.2009.07.034] [PMID: 19700254]
[9]
Vogl TJ, Nour-Eldin NA, Hammerstingl RM, Panahi B, Naguib NNN. Microwave Ablation (MWA): Basics, technique and results in primary and metastatic liver neoplasms - review article. RoFo Fortschr Geb Rontgenstr Nuklearmed 2017; 189(11): 1055-66.
[http://dx.doi.org/10.1055/s-0043-117410] [PMID: 28834968]
[10]
Vroomen LGPH, Petre EN, Cornelis FH, Solomon SB, Srimathveeravalli G. Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences? Diagn Interv Imaging 2017; 98(9): 609-17.
[http://dx.doi.org/10.1016/j.diii.2017.07.007] [PMID: 28869200]
[11]
Fan QY, Zhou Y, Zhang M, et al. Microwave ablation of malignant extremity bone tumors. Springerplus 2016; 5(1): 1373.
[http://dx.doi.org/10.1186/s40064-016-3005-8] [PMID: 27606161]
[12]
Fan QY, Zhou Y, Zhang M, et al. Microwave Ablation of Primary Malignant Pelvic Bone Tumors. Front Surg 2019; 6: 5.
[http://dx.doi.org/10.3389/fsurg.2019.00005] [PMID: 30891449]
[13]
Yu Z, Dong C, Zhang M, et al. Clinical evaluations of diaphysis malignant tumors of femur and tibia treated with microwave ablation in situ. J Orthop Surg Res 2020; 15(1): 139.
[http://dx.doi.org/10.1186/s13018-020-01662-1] [PMID: 32272956]
[14]
Yu Z, Geng J, Zhang M, Zhou Y, Fan Q, Chen J. Treatment of osteosarcoma with microwave thermal ablation to induce immunogenic cell death. Oncotarget 2014; 5(15): 6526-39.
[http://dx.doi.org/10.18632/oncotarget.2310] [PMID: 25153727]
[15]
Carrafiello G, Laganà D, Mangini M, et al. Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int J Surg 2008; 6(Suppl. 1): S65-9.
[http://dx.doi.org/10.1016/j.ijsu.2008.12.028] [PMID: 19186116]
[16]
Habash RW, Bansal R, Krewski D, Alhafid HT. Thermal therapy, Part III: ablation techniques. Crit Rev Biomed Eng 2007; 35(1-2): 37-121.
[http://dx.doi.org/10.1615/CritRevBiomedEng.v35.i1-2.20] [PMID: 17956222]
[17]
Hernández JI, Cepeda MF, Valdés F, Guerrero GD. Microwave ablation: state-of-the-art review. OncoTargets Ther 2015; 8: 1627-32.
[PMID: 26185452]
[18]
Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics 2005; 25(Suppl. 1): S69-83.
[http://dx.doi.org/10.1148/rg.25si055501] [PMID: 16227498]
[19]
Ji Y, Lu H. Malignancies in HIV-Infected and AIDS Patients. Adv Exp Med Biol 2017; 1018: 167-79.
[http://dx.doi.org/10.1007/978-981-10-5765-6_10] [PMID: 29052137]
[20]
Killebrew D, Shiramizu B. Pathogenesis of HIV-associated non-Hodgkin lymphoma. Curr HIV Res 2004; 2(3): 215-21.
[http://dx.doi.org/10.2174/1570162043351237] [PMID: 15279585]
[21]
Linke-Serinsöz E, Fend F, Quintanilla-Martinez L. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point. Semin Diagn Pathol 2017; 34(4): 352-63.
[http://dx.doi.org/10.1053/j.semdp.2017.04.003] [PMID: 28506687]
[22]
Geh JI, Spittle MF. Oncological problems in AIDS--a review of the clinical features and management. Ann Acad Med Singapore 1996; 25(3): 380-91.
[PMID: 8876905]
[23]
Kotrashetti VS, Kale AD, Hallikeremath SR, Mane DR, V Angadi P, Bhatt P. Intraosseous fibrosarcoma of maxilla in an HIV patient. Arch Iran Med 2012; 15(1): 59-62.
[PMID: 22208447]
[24]
Rabkin CS, Blattner WA. HIV infection and cancers other than non-Hodgkin lymphoma and Kaposi’s sarcoma. Cancer Surv 1991; 10: 151-60.
[PMID: 1821320]
[25]
Shiels MS, Engels EA. Evolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS 2017; 12(1): 6-11.
[http://dx.doi.org/10.1097/COH.0000000000000327] [PMID: 27749369]
[26]
Singh E, Naidu G, Davies MA, Bohlius J. HIV-associated malignancies in children. Curr Opin HIV AIDS 2017; 12(1): 77-83.
[http://dx.doi.org/10.1097/COH.0000000000000331] [PMID: 27685986]
[27]
Vangipuram R, Tyring SK. AIDS-Associated Malignancies. Cancer Treat Res 2019; 177: 1-21.
[http://dx.doi.org/10.1007/978-3-030-03502-0_1] [PMID: 30523619]
[28]
Yarchoan R, Uldrick TS. HIV-Associated Cancers and Related Diseases. N Engl J Med 2018; 378(11): 1029-41.
[http://dx.doi.org/10.1056/NEJMra1615896] [PMID: 29539283]
[29]
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17(6): 1471-4.
[30]
Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 1993; (286): 241-6.
[http://dx.doi.org/10.1097/00003086-199301000-00035] [PMID: 8425352]
[31]
Kastler A, Alnassan H, Aubry S, Kastler B. Microwave thermal ablation of spinal metastatic bone tumors. J Vasc Interv Radiol 2014; 25(9): 1470-5.
[http://dx.doi.org/10.1016/j.jvir.2014.06.007] [PMID: 25000826]
[32]
Pusceddu C, Sotgia B, Fele RM, Ballicu N, Melis L. Combined Microwave Ablation and Cementoplasty in Patients with Painful Bone Metastases at High Risk of Fracture. Cardiovasc Intervent Radiol 2016; 39(1): 74-80.
[http://dx.doi.org/10.1007/s00270-015-1151-y] [PMID: 26071108]
[33]
Pusceddu C, Sotgia B, Fele RM, Melis L. Treatment of bone metastases with microwave thermal ablation. J Vasc Interv Radiol 2013; 24(2): 229-33.
[http://dx.doi.org/10.1016/j.jvir.2012.10.009] [PMID: 23200605]
[34]
Ringe KI, Panzica M, von Falck C. Thermoablation of Bone Tumors. RoFo Fortschr Geb Rontgenstr Nuklearmed 2016; 188(6): 539-50.
[http://dx.doi.org/10.1055/s-0042-100477] [PMID: 26981915]
[35]
Aboulafia DM, Pantanowitz L, Dezube BJ. AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART. AIDS Read 2004; 14(11): 605-17.
[PMID: 15570672]
[36]
Bonnet F, Chêne G. Evolving epidemiology of malignancies in HIV. Curr Opin Oncol 2008; 20(5): 534-40.
[http://dx.doi.org/10.1097/CCO.0b013e32830a5080] [PMID: 19106656]
[37]
Gucalp A, Noy A. Spectrum of HIV lymphoma 2009. Curr Opin Hematol 2010; 17(4): 362-7.
[http://dx.doi.org/10.1097/MOH.0b013e328338f6b6] [PMID: 20442655]
[38]
Malfitano A, Barbaro G, Perretti A, Barbarini G. Human immunodeficiency virus-associated malignancies: a therapeutic update. Curr HIV Res 2012; 10(2): 123-32.
[http://dx.doi.org/10.2174/157016212799937227] [PMID: 22329518]
[39]
Mounier N, Spina M, Spano JP. Hodgkin lymphoma in HIV positive patients. Curr HIV Res 2010; 8(2): 141-6.
[http://dx.doi.org/10.2174/157016210790442704] [PMID: 20163350]
[40]
Sigel K, Makinson A, Thaler J. Lung cancer in persons with HIV. Curr Opin HIV AIDS 2017; 12(1): 31-8.
[http://dx.doi.org/10.1097/COH.0000000000000326] [PMID: 27607596]
[41]
Papagelopoulos PJ, Galanis EC, Vlastou C, et al. Current concepts in the evaluation and treatment of osteosarcoma. Orthopedics 2000; 23(8): 858-67.
[PMID: 10952054]
[42]
Reed DR, Hayashi M, Wagner L, et al. Treatment pathway of bone sarcoma in children, adolescents, and young adults. Cancer 2017; 123(12): 2206-18.
[http://dx.doi.org/10.1002/cncr.30589] [PMID: 28323337]
[43]
Tiwari A. Current concepts in surgical treatment of osteosarcoma. J Clin Orthop Trauma 2012; 3(1): 4-9.
[http://dx.doi.org/10.1016/j.jcot.2012.04.004] [PMID: 25983449]
[44]
Ahlmann ER, Menendez LR, Kermani C, Gotha H. Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb. J Bone Joint Surg Br 2006; 88(6): 790-5.
[http://dx.doi.org/10.1302/0301-620X.88B6.17519] [PMID: 16720775]
[45]
Benevenia J, Kirchner R, Patterson F, et al. Outcomes of a Modular Intercalary Endoprosthesis as Treatment for Segmental Defects of the Femur, Tibia, and Humerus. Clin Orthop Relat Res 2016; 474(2): 539-48.
[http://dx.doi.org/10.1007/s11999-015-4588-z] [PMID: 26475032]
[46]
Kim JD, Lee GW, Chung SH. A reconstruction with extracorporeal irradiated autograft in osteosarcoma around the knee. J Surg Oncol 2011; 104(2): 187-91.
[http://dx.doi.org/10.1002/jso.21902] [PMID: 21400535]
[47]
Mavrogenis AF, Abati CN, Romagnoli C, Ruggieri P. Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma. Clin Orthop Relat Res 2012; 470(6): 1735-48.
[http://dx.doi.org/10.1007/s11999-011-2238-7] [PMID: 22270466]
[48]
Schwartz AJ, Kabo JM, Eilber FC, Eilber FR, Eckardt JJ. Cemented distal femoral endoprostheses for musculoskeletal tumor: improved survival of modular versus custom implants. Clin Orthop Relat Res 2010; 468(8): 2198-210.
[http://dx.doi.org/10.1007/s11999-009-1197-8] [PMID: 20033359]
[49]
Takeuchi A, Yamamoto N, Hayashi K, et al. Joint-preservation surgery for pediatric osteosarcoma of the knee joint. Cancer Metastasis Rev 2019; 38(4): 709-22.
[http://dx.doi.org/10.1007/s10555-019-09835-z] [PMID: 31807972]
[50]
Tan PX, Yong BC, Wang J, et al. Analysis of the efficacy and prognosis of limb-salvage surgery for osteosarcoma around the knee. Eur J Surg Oncol 2012; 38(12): 1171-7.
[http://dx.doi.org/10.1016/j.ejso.2012.07.003] [PMID: 22809860]
[51]
Xu L, Zhou J, Wang Z, Xiong J, Qiu Y, Wang S. Reconstruction of bone defect with allograft and retrograde intramedullary nail for distal tibia osteosarcoma. Foot Ankle Surg 2018; 24(2): 149-53.
[http://dx.doi.org/10.1016/j.fas.2017.01.006] [PMID: 29409222]
[52]
Yoshida Y, Osaka S, Tokuhashi Y. Analysis of limb function after various reconstruction methods according to tumor location following resection of pediatric malignant bone tumors. World J Surg Oncol 2010; 8: 39.
[http://dx.doi.org/10.1186/1477-7819-8-39] [PMID: 20482815]
[53]
Ceruso M, Taddei F, Bigazzi P, Manfrini M. Vascularised fibula graft inlaid in a massive bone allograft: considerations on the bio-mechanical behaviour of the combined graft in segmental bone reconstructions after sarcoma resection. Injury 2008; 39(Suppl. 3): S68-74.
[http://dx.doi.org/10.1016/j.injury.2008.05.014] [PMID: 18707684]
[54]
Fuchs B, Ossendorf C, Leerapun T, Sim FH. Intercalary segmental reconstruction after bone tumor resection. Eur J Surg Oncol 2008; 34(12): 1271-6.
[http://dx.doi.org/10.1016/j.ejso.2007.11.010] [PMID: 18191363]
[55]
Thompson RC Jr, Garg A, Clohisy DR, Cheng EY. Fractures in large-segment allografts. Clin Orthop Relat Res 2000; (370): 227-35.
[http://dx.doi.org/10.1097/00003086-200001000-00023] [PMID: 10660718]
[56]
Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 2014; 14(3): 199-208.
[http://dx.doi.org/10.1038/nrc3672] [PMID: 24561446]

Rights & Permissions Print Cite
Article Metrics
29
3
World Immunization Week
© 2024 Bentham Science Publishers | Privacy Policy